zzaatt, what's better? New shares authorized which eventually become new shares issued ...OR no options, ie company has to accept being bought out by another.
Stated that way I'd take the latter, it's just not clear to me that it would be a BO deal that we would like. In other words, how does a company get valuation when it's essentially bankrupt and it's up against the wall?
What if good clinical results are coming down the pike, but the company needs a little more time (and funds to sustain it). The problem is that we can invent any number of scenarios and try to game it out, but we have substantially less information than management, and even they're facing uncertainties (such as unexpected outcomes, good or bad, timing of milestones, etc.)
For me it's a necessary working assumption that management is doing it's best, given what they have to work with (past mistakes not withstanding). If my only option is to try to constrain management's freedom of action, I might as well give up and sell.